vir-2482
Vaccineexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 26, 2019 (NCT04033406)
Timeline
Indications
Studied for
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05567783 | Phase 2 | Oct 30, 2022 | Vir Biotechnology, Inc. |
| NCT04033406 | Phase 1/Phase 2 (Phase 2) | Aug 26, 2019 | Vir Biotechnology, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Vir Biotechnology, Inc. | For profit | 2 | 2 | 1 | 2019 |
1 organizations
Page 1 / 1